Impact of recombinant erythropoietin on sexual function in hemodialysis patients.
Schaefer
R M
RM
Department of Internal Medicine, University of Würzburg, FRG.
Kokot
F
F
Heidland
A
A
D000328:Adult; D000740:Anemia / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D011388:Prolactin / Q000097:blood; D006435:Renal Dialysis; D012735:Sexual Dysfunction, Physiological / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D013739:Testosterone / Q000097:blood; D014511:Uremia / Q000097:blood / Q000150:complications / Q000628:therapy
D010281:Parathyroid Hormone; D004921:Erythropoietin; D013739:Testosterone; D011388:Prolactin